We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer to Dominate Schizophrenia Market After 2010, Analysis Says
Pfizer to Dominate Schizophrenia Market After 2010, Analysis Says
August 11, 2006
By 2010, generics will dominate the schizophrenia drug market, and Pfizer will be the only major drug firm to maintain a strong position after its current leading antipsychotic goes generic, according to an Aug. 11 report by research firm Datamonitor.